Transgene: A Positive 2018, Moving Ahead with a Strong Portfolio
2018 Full-year results and business update Clinical trials set to announce key data in 2019 Invir.IO™ platform designed to deliver…
Pharmaceuticals, Biotechnology and Life Sciences
2018 Full-year results and business update Clinical trials set to announce key data in 2019 Invir.IO™ platform designed to deliver…
SHANGHAI–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Shanghai?src=hash" target="_blank"gt;#Shanghailt;/agt;–To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center…
ANN ARBOR, Mich. & LANSING, Mich.–(BUSINESS WIRE)–Michigan’s premier biosciences industry trade organization, MichBio, presents its annual Michigan Biosciences Day at…
PDM Healthcare GPO members to have access to traditional and Rapid Credit Program Box and Ship services CHICAGO–(BUSINESS WIRE)–Pharma Logistics…
DUBLIN–(BUSINESS WIRE)–The “Latin America Pharmaceutical Excipients Market by Functionality (Fillers, Coating, Disintegrants, Binders, Lubricants, Preservatives, Emulsifying Agents, Lubricants, Glidants, Diluents),…
Sage Therapeutics got clearance from the FDA has approved Zulresso (brexanolone) injection for the treatment of postpartum depression (PPD), and is the first and only medicine specifically approved to treat PPD, the most common medical complication of childbirth.
March 22 is National Lynch Syndrome Awareness Day and March is Colorectal Cancer Awareness Month MADISON, Wis.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRC?src=hash" target="_blank"gt;#CRClt;/agt;–Ahead…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the addition…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cydan, an orphan drug accelerator dedicated to creating therapies that improve the lives of people living with rare…
DUBLIN–(BUSINESS WIRE)–The “Flow Cytometry Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…